Lipoprotein(a): Emerging insights and therapeutics-Reference-Cited by-同舟云学术

Lipoprotein(a): Emerging insights and therapeutics

Published:2024-06 Issue: Volume:18 Page:100641
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Kaur Gurleen^ORCID,Abdelrahman Khaled,Berman Adam N.^ORCID,Biery David W.^ORCID,Shiyovich Arthur,Huck Daniel^ORCID,Garshick Michael,Blankstein Ron,Weber Brittany^ORCID

Funder

AHA

Publisher

Elsevier BV

Reference142 articles.

1. Current and future role of Lipoprotein(a) in preventive cardiology;Berman;Curr Opin Cardiol,2019

2. Prevalence of elevated Lp(a) mass levels and patient thresholds in 532 359 patients in the United States;Varvel;Arterioscler Thromb Vasc Biol,2016

3. Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort;Brandt;J Clin Lipidol,2020

4. Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community;Lieb;Open Heart,2018

5. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin);Khera;Circulation,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crucial Interactions between Altered Plasma Trace Elements and Fatty Acids Unbalance Ratio to Management of Systemic Arterial Hypertension in Diabetic Patients: Focus on Endothelial Dysfunction;International Journal of Molecular Sciences;2024-08-27